ArticleThe journal of physical chemistry. B2026
Inclusion Complexation of Native and Functionalized α-, β-, and γ-Cyclodextrins with PFAS: An Experimental and Molecular Simulation Study.
Article in The journal of physical chemistry. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
β-Cyclodextrin (β-CD)-based polymers have shown high adsorption capacities for removing per- and polyfluoroalkyl substances (PFAS) from drinking water. PFAS capture by these materials involves many physical and chemical processes, such as adsorption and inclusion complexation. Quantifying the underlying host-guest binding between CDs and PFAS nevertheless remains essential because it governs the primary inclusion step. Here, we investigated native and linker-modified CD-PFAS inclusion complexes in aqueous solution using isothermal titration calorimetry (ITC) and molecular dynamics (MD) simulations with the attach-pull-release (APR) method. We computed the Gibbs free energies of binding for α-, β-, and γ-CDs with seven linear PFAS, including perfluorocarboxylic acids and perfluorosulfonic acids, and found reasonable agreement with our experimental measurements and previously reported data. Comparison between implicit and explicit solvent calculations suggests that the apparently better agreement of the implicit solvent model for some native monomer complexes is likely due to error cancellation rather than a more transferable physical description, whereas explicit solvent is required to capture solvent-related salt and linker effects. Overall, β-CD exhibited the strongest binding affinities, whereas α-CD showed negligible affinities and γ-CD bound PFAS more weakly than β-CD. Hydrogen bonding, interaction-energy decomposition, and solvent-accessible surface area showed that host-guest hydrogen bonding cannot uniquely predict affinities, and that hydrophobic dehydration plays a dominant role in binding. We further examined how background ion concentration affects β-CD-PFAS binding and found that explicit solvent simulations capture a clear salt dependence, with Li/Merz ion parameters describing the high-salinity trend more reasonably than the Joung-Cheatham model. To mimic the local microenvironment surrounding CD units in polymers, we also examined three linker-modified β-CD models containing phenyl groups. Bind3P water correctly reproduced the experimentally reported enhancement of PFAS adsorption with increasing linker number, and energy decomposition showed that linker groups strengthen PFAS binding by enhancing local hydrophobic confinement and specific linker-guest interactions. Overall, this combined experimental and computational study provides molecular-level insight into the building blocks of cyclodextrin polymers and lays the groundwork for future in silico construction of CD polymer models for PFAS adsorption under diverse water-matrix conditions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.